Sagimet Biosciences Inc. - Series A · NASDAQ:SGMT
Commodore Capital LP reported a 7.60% stake in Sagimet Biosciences Inc. - Series A (Schedule 13G)
Event Sep 30, 2026 · Filed Oct 7, 2026
Commodore Capital LP reported a 7.60% stake in Sagimet Biosciences Inc. - Series A, 5,507,752 shares, as a passive investor on Sep 30, 2026. Filed Oct 7, 2026 (Schedule 13G).
- Stake
- 7.60%
- Shares
- 5,507,752
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Commodore Capital LP | 7.60% | 5,507,752 |
| Commodore Capital Master LP | 7.60% | 5,507,752 |
| Robert Egen Atkinson | 7.60% | 5,507,752 |
| Michael Kramarz | 7.60% | 5,507,752 |
Source
Related
- Sagimet Biosciences Inc. - Series A
- Commodore Capital LP
- Sagimet Biosciences Inc. - Series A shareholders
- Form 4 · Kemble George · Aug 17, 2026
- Schedule 13G · Balyasny Asset Management L.P. · Aug 14, 2026
- Form 4 · Kemble George · Aug 12, 2026
- Schedule 13G · BlackRock, Inc. · Jul 30, 2026
- Form 4 · Happel David · Jul 22, 2026